Description

Abiflox (levofloxacin) Coated Tablets 500 mg. №10

Ingredients

Active ingredient: Levofloxacin 500 mg.
Other ingredients: Microcrystalline cellulose, crospovidone, magnesium stearate, hypromellose, titanium dioxide, polyethylene glycol.

Dosage

Recommended dosage: 1 tablet daily, or as prescribed by a healthcare professional.
Do not crush or chew the tablet; swallow it whole with a full glass of water.

Indications

Abiflox (levofloxacin) coated tablets are indicated for the treatment of bacterial infections such as sinusitis, pneumonia, skin infections, urinary tract infections, and bronchitis.

Contraindications

Do not use Abiflox (levofloxacin) coated tablets if:

• You have a history of tendon problems after taking fluoroquinolones.
• You are pregnant or breastfeeding.
• You have a history of seizures.

Directions

Take Abiflox (levofloxacin) coated tablets exactly as prescribed by your healthcare provider.
Complete the full course of medication even if you start to feel better.

Scientific Evidence

Levofloxacin, the active ingredient in Abiflox tablets, has been extensively studied for its efficacy in treating various bacterial infections. Research published in the Journal of Antimicrobial Chemotherapy demonstrated the high potency of levofloxacin against a wide range of pathogens, making it a valuable choice for empirical therapy.

Additional Information

It is important to note that levofloxacin may cause tendonitis and tendon rupture, especially in patients over 60 years old. If you experience any joint pain or inflammation, discontinue the medication and consult your healthcare provider immediately.

Pharmacological Effects: Levofloxacin works by inhibiting bacterial DNA gyrase, thereby disrupting DNA replication and leading to bacterial cell death. It has a broad spectrum of activity against both Gram-positive and Gram-negative bacteria.

Clinical Trials: Clinical trials have shown that Abiflox (levofloxacin) coated tablets are comparable in efficacy to other fluoroquinolones in the treatment of respiratory and urinary tract infections. A study published in the European Respiratory Journal found that levofloxacin was highly effective in treating community-acquired pneumonia.